PMCA-replicated PrP(D) in urine of vCJD patients maintains infectivity and strain characteristics of brain PrP(D): Transmission study

在变异型克雅氏病(vCJD)患者尿液中,经PMCA复制的PrP(D)保持了脑组织PrP(D)的感染性和毒株特征:传播研究

阅读:2

Abstract

The presence of abnormal, disease-related prion protein (PrP(D)) has recently been demonstrated by protein misfolding cyclic amplification (PMCA) in urine of patients affected with variant Creutzfeldt-Jakob disease (vCJD), a prion disease typically acquired from consumption of prion contaminated bovine meat. The complexity and multistage process of urine excretion along with the obligatory use of PMCA raise the issue of whether strain characteristics of the PrP(D) present in vCJD brains, such as infectivity and phenotype determination, are maintained in urine excreted PrP(D) and following amplification by PMCA. We inoculated transgenic mice expressing normal human PrP with amplified urine and brain homogenate achieving the same 100% attack rate, similar incubation periods (in both cases extremely long) and histopathological features as for type and severity of the lesions. Furthermore, PrP(D) characteristics analyzed by immunoblot and conformational stability immunoassay were indistinguishable. Inoculation of raw vCJD urine caused no disease, confirming the extremely low concentration of PrP(D) in vCJD urine. These findings show that strain characteristics of vCJD brain PrP(D), including infectivity, are preserved in PrP(D) present in urine and are faithfully amplified by means of PMCA; moreover, they suggest that the PrP(D) urine test might allow for the diagnosis and identification of disease subtype also in sporadic CJD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。